Spasticity in Adults Living in a Developmental Center

Archives of Physical Medicine and Rehabilitation

Volumn 84, Issue 12, 2003, Pages 1808-1812

  Pfister, Alyssa A ^a   Roberts, Amanda G ^a   Taylor, Henry M ^b   Noel Spaudling, Shayla ^b   Damian, M Myrandele ^a   Charles, P David ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Clover Bottom Developmental Center   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Activities of daily living; Cerebral palsy; Mental retardation; Muscle spasticity; Rehabilitation; Residential facilities

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CEREBRAL PALSY; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DEVELOPMENTAL DISORDER; DOCUMENTATION; FEMALE; HAND; HEALTH CARE FACILITY; HUMAN; HYGIENE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL DEFICIENCY; MOBILIZATION; OCCUPATIONAL THERAPY; ORTHOPEDIC SURGERY; PATIENT TRANSPORT; PHYSIOTHERAPY; PREVALENCE; SPASTICITY; SPLINTING; TEAMWORK; TREATMENT INDICATION; TREATMENT PLANNING; WHEELCHAIR;

EID: 0348220494     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(03)00368-X     Document Type: Article

References (32)

1. Thompson FJ, Parmer R, Reier PJ, Wang DC, Bose P. Scientific basis of spasticity: insights from a laboratory model. J Child Neurol 2001;16:2-7.
2. Gormley ME, O'Brien CF, Yablon SA. A clinical overview of treatment decisions in the management of spasticity. Muscle Nerve 1997;20(Suppl 6):14-20.
3. Goldstein EM. Spasticity management: an overview. J Child Neurol 2001;16:16-23.
4. Bjornson KF. Role of the physical therapist in the management of children with spasticity. In: Damiano D, editor. Topics in physical therapy-pediatrics. Alexandria (VA): American Physical Therapy Association; 2001. p 8:1-16.
5. Russman BS, Tilton A, Gormley ME. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment. Muscle Nerve 1997;20(Suppl 6):181-93.
6. Edgar TS. Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review. J Child Neurol 2001;16:37-45.
7. Yablon SA. Botulinum neurotoxin intramuscular chemodenervation. Phys Med Rehabil Clin North Am 2001;12:833-68.
8. Ivanhoe CB, Tilton AH, Francisco GE. Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehabil Clin North Am 2001;12:923-36.
9. Boop FA. Evolution of the neurosurgical management of spasticity. J Child Neurol 2001;16:54-7.
10. Albright AL. Baclofen in the treatment of cerebral palsy. J Child Neurol 1996;11:77-83.
11. Chambers HG. The surgical treatment of spasticity. Muscle Nerve 1997;20(Suppl 6):121-8.
12. Smyth MD, Peacock WJ. The surgical treatment of spasticity. Muscle Nerve 2000;23:153-63.
13. Gates J, Huf R, Frost M. Vagus nerve stimulation for patients in residential treatment facilities. Epilepsy Behav 2001;2:563-7.
14. Tyler CV, Bourguet C. Primary care of adults with mental retardation. J Fam Pract 1997;44:487-94.
15. Martin BA. Primary care of adults with mental retardation living in the community. Am Fam Physician 1997;56:485-94.
16. Closing the gap: a national blueprint to improve the health of persons with mental retardation-report of the Surgeon General's Conference of Health Disparities and Mental Retardation. Rockville (MD): US Dept of Health and Human Services, Public Health Service, Office of the Surgeon General; 2002.
17. Minihan PM, Dean DH, Lyons CM. Managing the care of patients with mental retardation: a survey of physicians. Ment Retard 1993;31:239-46.
18. Bottos M, Feliciangeli A, Sciuto L, Gericke C, Vianello A. Functional status of adults with cerebral palsy and implications for treatment of children. Dev Med Child Neurol 2001;43:516-28.
19. Murphy KP, Molnar GE, Lankasky K. Medical and functional status of adults with cerebral palsy. Dev Med Child Neurol 1995;37:1075-84.
20. Nelson RP, Crocker AC. The medical care of mentally retarded persons in public residential facilities. N Engl J Med 1978;299:1039-44.
21. Mahlow WJ, Powers J, Taylor H, Smart J. Improvement in outcome in an LTC institution after development of a systems approach to chronic disease management. Long-Term Care Interface 2003;4:36-40.
22. Brown K. They are improved, but are they better [editorial]? Dev Med Child Neurol 1997;39:213.
23. Hinderer SR, Dixon K. Physiologic and clinical monitoring of spastic hypertonia. Phys Med Rehabil Clin North Am 2001;12:733-43.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, rev. Washington (DC): APA; 2000.
25. Kuban KC, Leviton A. Cerebral palsy. N Engl J Med 1994;330:188-95.
26. Nelson WE, Vaughan VC, McKay RJ, Behrman RE, editors. Nelson textbook of pediatrics. 11th ed. Philadelphia: WB Saunders; 1979. p 1759-61.
27. Blair E, Stanley FJ. Issues in the classification and epidemiology of cerebral palsy. Ment Retard Dev Disabil Res Rev 1997;3:184-93.
28. UCP Research & Educational Foundation. Research fact sheets: general info. Statistics, 11/1994. Available at: http://www. ucpa.org/ucp_generaldoc.cfm/1/4/24/24-6607/152. Accessed March 17, 2003.
29. Strauss D, Shavelle R. Life expectancy of adults with cerebral palsy. Dev Med Child Neurol 1998;40:369-75.
30. Maruishi M, Mano Y, Sasaki T, Shinmyo N, Sato H, Ogawa T. Cerebral palsy in adults: independent effects of muscle strength and muscle tone. Arch Phys Med Rehabil 2001;82:637-41.
31. Andersson C, Mattsson E. Adults with cerebral palsy: a survey describing problems, needs, and resources, with special emphasis on locomotion. Dev Med Child Neurol 2001;43:76-82.
32. Petersen MC, Palmer FB. Advances in prevention and treatment of cerebral palsy. Ment Retard Dev Disabil Res Rev 2001;7:30-7.